Skip to content

Endoscopic Transnasal Optic Canal Decompression for Traumatic Optic Neuropathy in Children: A Prospective Real-World Study on Efficacy, Safety, and Prognostic Factors at a Single Center

Endoscopic Transnasal Optic Canal Decompression for Traumatic Optic Neuropathy in Children: A Prospective Real-World Study on Efficacy, Safety, and Prognostic Factors at a Single Center

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128234
Enrollment
Unknown
Registered
2026-07-16
Start date
2026-07-19
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Optic Neuropathy

Interventions

S3 Non-surgical Conservative Strategy Group: Decision not to undergo ETOCD:None
S2 Initial Steroid Strategy Group:None
S1 Early ETOCD Strategy Group:None

Sponsors

Beijing Childrens Hospital,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1.Pediatric age group: 0–18 years; 2. A definitive history of craniofacial trauma, with the initial specialist evaluation for TON conducted at our institution within =4 years, or poor/absent light pursuit and grasping reflexes in those =7 years; subjects aged >=16 years with full civil capacity may self-consent);

Exclusion criteria

Exclusion criteria: 1.Ruptured eyeball, optic nerve transection, or open craniocerebral injury requiring emergency craniotomy; 2.Concomitant severe intracranial hematoma (midline shift >5 mm) or signs of brain herniation; 3.Pre-existing underlying diseases affecting vision, such as optic nerve developmental abnormalities, glaucoma, or retinopathy; 4.Pre-injury ipsilateral amblyopia or blindness in the affected eye; 5.Severe concurrent ocular injuries that preclude differentiation of the source of vision loss (e.g., severe vitreous hemorrhage, retinal detachment, macular laceration, etc.), which may serve as an exclusion criterion or a preset condition for sensitivity analysis; 6.Inability to complete the 6-month follow-up (e.g., patients from other regions unwilling to return to the hospital and unable to provide local ophthalmological examination reports);

Design outcomes

Primary

MeasureTime frame
6-Month Visual Improvement;

Secondary

MeasureTime frame
Optical Coherence Tomography;Visual Evoked Potential improvement;Rate of Visual Improvement at 1 Week and 1 Month Postoperatively;

Countries

China

Contacts

Public ContactNi Xin

Beijing Childrens Hospital,Capital Medical University

nixin@bch.com.cn+86 10 59616083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026